1. Home
  2. LICN vs GKOS Comparison

LICN vs GKOS Comparison

Compare LICN & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LICN
  • GKOS
  • Stock Information
  • Founded
  • LICN 2004
  • GKOS 1998
  • Country
  • LICN China
  • GKOS United States
  • Employees
  • LICN N/A
  • GKOS N/A
  • Industry
  • LICN
  • GKOS Medical/Dental Instruments
  • Sector
  • LICN
  • GKOS Health Care
  • Exchange
  • LICN Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • LICN 2.1M
  • GKOS 5.1B
  • IPO Year
  • LICN 2023
  • GKOS 2015
  • Fundamental
  • Price
  • LICN $3.68
  • GKOS $93.79
  • Analyst Decision
  • LICN
  • GKOS Strong Buy
  • Analyst Count
  • LICN 0
  • GKOS 13
  • Target Price
  • LICN N/A
  • GKOS $155.00
  • AVG Volume (30 Days)
  • LICN 94.8K
  • GKOS 1.0M
  • Earning Date
  • LICN 01-01-0001
  • GKOS 04-30-2025
  • Dividend Yield
  • LICN N/A
  • GKOS N/A
  • EPS Growth
  • LICN 36.90
  • GKOS N/A
  • EPS
  • LICN 55.10
  • GKOS N/A
  • Revenue
  • LICN $41,929,000.00
  • GKOS $383,481,000.00
  • Revenue This Year
  • LICN N/A
  • GKOS $27.84
  • Revenue Next Year
  • LICN N/A
  • GKOS $27.99
  • P/E Ratio
  • LICN $0.07
  • GKOS N/A
  • Revenue Growth
  • LICN 24.86
  • GKOS 21.85
  • 52 Week Low
  • LICN $0.04
  • GKOS $77.91
  • 52 Week High
  • LICN $7.55
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • LICN 53.16
  • GKOS 46.82
  • Support Level
  • LICN $2.60
  • GKOS $92.79
  • Resistance Level
  • LICN $4.90
  • GKOS $97.38
  • Average True Range (ATR)
  • LICN 0.51
  • GKOS 4.43
  • MACD
  • LICN -0.00
  • GKOS 1.61
  • Stochastic Oscillator
  • LICN 46.96
  • GKOS 72.39

About LICN Lichen China Limited

Lichen International Ltd formerly Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: